Article
Epigenetic reprogramming in breast cancer: from new targets to new therapies.
Annals of medicine - 1 Sept 2014
Katz Tiffany A, Huang Yi, Davidson Nancy E, Jankowitz Rachel C
Abstract excerpt
Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among women in the United States. Recently, interest has grown in the role of epigenetics in breast cancer development and progression. Epigenetic changes such as DNA methylation, histone modifications, and abnormal expression of non-coding RNAs emerged as novel biomarkers in breast cancer diagnosis, therapy, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
